Clinical Trials Browser

Interventional × Pneumonia × 30 days × Clear all

NCT05962606 2026-03-18

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

Phase 2 Completed

Community-Acquired Pneumonia, Lymphoma, Follicular, Pneumonia